Zimmer Holdings Inc.’s motion for summary judgment on the invalidity of certain claims of Howmedica Osteonics Corp.’s U.S. Patent No. 6,818,020 remains pending in the U.S. District Court for the…
Laboratory Corp. of American Holdings Inc. continues to face the remaining issues in the patent suit filed by Competitive Technologies Inc. and Metabolite Laboratories Inc. in the U.S. District Court…
Schering-Plough Corp.’s patent infringement action against companies seeking approval of a generic version of certain strengths of Temodar capsules is still pending.
The Company and its licensor, Cancer Research Technologies, Limited,…
Several purported antitrust class actions filed in the federal and state courts against Schering-Plough Corp. with regards to the drug, K-DUR, are still in discovery.
Schering-Plough had settled patent litigation with…
Schering-Plough Corp. and an entity jointly owned with Merck & Co., Inc. continue to pursue a patent infringement action against companies seeking approval of a generic version of ZETIA.
The action…
The Court of Appeals for the Federal Circuit, on July 21, 2008, affirmed the decision upholding the enforceability of the patent on ACIPHEX(R), according to Johnson & Johnson’s Form 10-Q…
Schering-Plough Corp. is pursuing patent infringement actions against companies seeking approval of generic versions of Clarinex Tablets, Clarinex Reditabs and Clarinex D12.
The Company filed these actions in September 2006. (Lloyds…
Dr. Gregory W. Baran’s suit against Medical Device Technologies Inc. for the infringement of U.S. Patent Nos. 5,025,797 and 5,400,798 is in the discovery phase.
Medical Device Technologies is a…